Cargando…
p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792244/ https://www.ncbi.nlm.nih.gov/pubmed/32750288 http://dx.doi.org/10.1161/JAHA.120.017247 |
_version_ | 1783633762424193024 |
---|---|
author | Saleme, Bruno Das, Subhash K. Zhang, Yongneng Boukouris, Aristeidis E. Lorenzana Carrillo, Maria Areli Jovel, Juan Wagg, Cory S. Lopaschuk, Gary D. Michelakis, Evangelos D. Sutendra, Gopinath |
author_facet | Saleme, Bruno Das, Subhash K. Zhang, Yongneng Boukouris, Aristeidis E. Lorenzana Carrillo, Maria Areli Jovel, Juan Wagg, Cory S. Lopaschuk, Gary D. Michelakis, Evangelos D. Sutendra, Gopinath |
author_sort | Saleme, Bruno |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7792244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77922442021-01-15 p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology Saleme, Bruno Das, Subhash K. Zhang, Yongneng Boukouris, Aristeidis E. Lorenzana Carrillo, Maria Areli Jovel, Juan Wagg, Cory S. Lopaschuk, Gary D. Michelakis, Evangelos D. Sutendra, Gopinath J Am Heart Assoc Research Letter John Wiley and Sons Inc. 2020-07-29 /pmc/articles/PMC7792244/ /pubmed/32750288 http://dx.doi.org/10.1161/JAHA.120.017247 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Letter Saleme, Bruno Das, Subhash K. Zhang, Yongneng Boukouris, Aristeidis E. Lorenzana Carrillo, Maria Areli Jovel, Juan Wagg, Cory S. Lopaschuk, Gary D. Michelakis, Evangelos D. Sutendra, Gopinath p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology |
title | p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology |
title_full | p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology |
title_fullStr | p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology |
title_full_unstemmed | p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology |
title_short | p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology |
title_sort | p53‐mediated repression of the pgc1a (pparg coactivator 1α) and aplnr (apelin receptor) signaling pathways limits fatty acid oxidation energetics: implications for cardio‐oncology |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792244/ https://www.ncbi.nlm.nih.gov/pubmed/32750288 http://dx.doi.org/10.1161/JAHA.120.017247 |
work_keys_str_mv | AT salemebruno p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT dassubhashk p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT zhangyongneng p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT boukourisaristeidise p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT lorenzanacarrillomariaareli p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT joveljuan p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT waggcorys p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT lopaschukgaryd p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT michelakisevangelosd p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology AT sutendragopinath p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology |